Published in Lancet Oncol on February 01, 2005
Imaging oxygenation of human tumours. Eur Radiol (2006) 1.78
Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. Radiother Oncol (2009) 1.59
Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol (2012) 1.57
Detoxification of gold nanorods by treatment with polystyrenesulfonate. ACS Nano (2008) 1.42
Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin Radiat Oncol (2011) 1.35
Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. Phys Med Biol (2008) 1.23
Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. Semin Radiat Oncol (2009) 1.20
Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes. Int J Radiat Oncol Biol Phys (2006) 1.18
PET-CT for radiotherapy treatment planning and response monitoring in solid tumors. Nat Rev Clin Oncol (2011) 1.11
New challenges in high-energy particle radiobiology. Br J Radiol (2014) 1.08
Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study. Phys Med Biol (2007) 1.06
On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function. Phys Med Biol (2009) 1.04
The physical basis and future of radiation therapy. Br J Radiol (2011) 0.99
Radiation oncology in the era of precision medicine. Nat Rev Cancer (2016) 0.97
Randomized controlled trials in health technology assessment: overkill or overdue? Radiother Oncol (2008) 0.97
Feasibility of dose painting using volumetric modulated arc optimization and delivery. Acta Oncol (2010) 0.96
Functional MRI for radiotherapy dose painting. Magn Reson Imaging (2012) 0.92
Imaging in radiation oncology: a perspective. Oncologist (2010) 0.92
PET imaging for the quantification of biologically heterogeneous tumours: measuring the effect of relative position on image-based quantification of dose-painting targets. Phys Med Biol (2010) 0.91
A 4D IMRT planning method using deformable image registration to improve normal tissue sparing with contemporary delivery techniques. Radiat Oncol (2011) 0.89
Reproducibility of four-dimensional computed tomography-based lung ventilation imaging. Acad Radiol (2012) 0.89
Feasibility and sensitivity study of helical tomotherapy for dose painting plans. Acta Oncol (2010) 0.88
From anatomical to biological target volumes: the role of PET in radiation treatment planning. Cancer Imaging (2006) 0.87
Evaluating target cold spots by the use of tail EUDs. Int J Radiat Oncol Biol Phys (2008) 0.87
Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol (2014) 0.87
Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study. Radiat Oncol (2013) 0.86
Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study. Radiat Oncol (2014) 0.85
On Voxel based Iso-Tumor Control Probabilty and Iso-Complication Maps for Selective Boosting and Selective Avoidance Intensity Modulated Radiotherapy. Imaging Decis (Berl) (2008) 0.85
PET in the management of locally advanced and metastatic NSCLC. Nat Rev Clin Oncol (2015) 0.84
A phantom model demonstration of tomotherapy dose painting delivery, including managed respiratory motion without motion management. Phys Med Biol (2010) 0.84
The impact of functional imaging on radiation medicine. Radiat Oncol (2008) 0.84
PET imaging biomarkers in head and neck cancer. Eur J Nucl Med Mol Imaging (2015) 0.83
Predictive treatment management: incorporating a predictive tumor response model into robust prospective treatment planning for non-small cell lung cancer. Int J Radiat Oncol Biol Phys (2013) 0.83
Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients. Radiother Oncol (2015) 0.83
Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective. Clin Transl Med (2012) 0.82
Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities. J Thorac Dis (2014) 0.82
Spatially resolved regression analysis of pre-treatment FDG, FLT and Cu-ATSM PET from post-treatment FDG PET: an exploratory study. Radiother Oncol (2012) 0.81
On the impact of functional imaging accuracy on selective boosting IMRT. Phys Med (2008) 0.80
Kill-painting of hypoxic tumours in charged particle therapy. Sci Rep (2015) 0.79
Positron emission tomography to assess hypoxia and perfusion in lung cancer. World J Clin Oncol (2014) 0.79
On the importance of prompt oxygen changes for hypofractionated radiation treatments. Phys Med Biol (2013) 0.78
Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy. Int J Radiat Oncol Biol Phys (2014) 0.78
Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review. Front Oncol (2012) 0.78
Imaging of tumour hypoxia using PET and 18F-labelled tracers: biology meets technology. Eur J Nucl Med Mol Imaging (2007) 0.77
Is there room for combined modality treatments? Dosimetric comparison of boost strategies for advanced head and neck and prostate cancer. J Radiat Res (2013) 0.77
Functional imaging for radiotherapy treatment planning: current status and future directions-a review. Br J Radiol (2015) 0.77
Spatio-Temporal Dynamics of Hypoxia during Radiotherapy. PLoS One (2015) 0.76
Feasibility of functional imaging for brachytherapy. J Contemp Brachytherapy (2009) 0.76
Short-course PET based simultaneous integrated boost for locally advanced cervical cancer. Radiat Oncol (2016) 0.76
A mechanistic study of gold nanoparticle radiosensitisation using targeted microbeam irradiation. Sci Rep (2017) 0.75
Validation of functional imaging as a biomarker for radiation treatment response. Br J Radiol (2015) 0.75
A segmentation framework towards automatic generation of boost subvolumes for FDG-PET tumors: a digital phantom study. Eur J Radiol (2012) 0.75
We should not settle for low-level evidence but should always use the best available evidence. J Gynecol Oncol (2014) 0.75
Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc. Radiat Oncol (2017) 0.75
Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study. Phys Med Biol (2015) 0.75
Multi-observation PET image analysis for patient follow-up quantitation and therapy assessment. Phys Med Biol (2011) 0.75
Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma. Radiat Oncol (2015) 0.75
Image fusion techniques in permanent seed implantation. J Contemp Brachytherapy (2010) 0.75
Dose-painting by numbers: a feasible approach? Lancet Oncol (2005) 0.75
Towards multidimensional radiotherapy: key challenges for treatment individualisation. Comput Math Methods Med (2015) 0.75
Pharmacokinetic modeling of a novel hypoxia PET tracer [(18)F]HX4 in patients with non-small cell lung cancer. EJNMMI Phys (2016) 0.75
Nothing new under the nuclear sun: towards 80 years of theranostics in nuclear medicine. Eur J Nucl Med Mol Imaging (2013) 0.75
Functional lung avoidance and response-adaptive escalation (FLARE) RT: multimodality plan dosimetry of a precision radiation oncology strategy. Med Phys (2017) 0.75
Personalized radiotherapy treatment planning based on functional imaging. Rep Pract Oncol Radiother (2017) 0.75
[Testicular tumor--yesterday--today--tomorrow]. Urologe A (2006) 0.75